Who Owns Knight Company?

Knight Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns Knight Therapeutics Inc.?

Understanding a company's ownership is key to grasping its strategic direction and market position. Knight Therapeutics Inc. became a public entity on February 28, 2014, following a spin-off from Paladin Labs Inc. after Paladin's assets were acquired by Endo Pharmaceuticals.

Founded in November 2013 as a Paladin Labs subsidiary, Knight Therapeutics Inc. aimed to build a robust portfolio of pharmaceutical products for Canada and Latin America. The company's growth is evident in its 2024 revenue of $371.3 million, with projections for 2025 between $390 million and $405 million.

Knight Therapeutics Inc.'s ownership is a mix of its founder's holdings, institutional investors, and the public. This structure influences its operations and strategic decisions, including its Knight PESTEL Analysis.

Knight Therapeutics Inc. was established in November 2013 by Jonathan Ross Goodman, a key figure also involved in the 1995 co-founding of Paladin Labs Inc. Goodman transitioned from CEO to Executive Chairman in August 2021, maintaining a significant role in the company’s direction. The company's inception was marked by a unique spin-off event, distributing Knight Therapeutics to Paladin's shareholders following the acquisition of most of Paladin Labs' assets by Endo Pharmaceuticals for $3 billion in 2014.

Founding Visionary

Jonathan Ross Goodman, the founder of Knight Therapeutics, also co-founded its predecessor, Paladin Labs Inc. His leadership has been instrumental in shaping the company's strategic path since its inception.

Inception Through Spin-Off

Knight Therapeutics was established via a spin-off from Paladin Labs Inc. This occurred after Paladin's assets were acquired, making Knight a public entity from its start.

Initial Shareholder Base

The original shareholders of Paladin Labs Inc. became the first owners of Knight Therapeutics Inc. This distribution occurred on February 28, 2014, establishing the initial Knight Company ownership.

Goodman's Continued Influence

Jonathan Ross Goodman, who served as CEO until August 31, 2021, continues to hold a vital position as Executive Chairman. His ongoing involvement ensures continuity in the company's strategic direction.

Largest Individual Shareholder

As of April 1, 2025, Jonathan Ross Goodman remains the primary individual shareholder. His direct and indirect holdings underscore his significant stake and control within Knight Therapeutics Inc.

Shareholding Details

Goodman directly owns 962,995 common shares and controls an additional 20,760,733 shares through Long Zone Holdings Inc. His family also holds 43,300 shares, totaling 21,786,461 shares under his influence.

The ownership structure of Knight Therapeutics Inc. was established through a strategic spin-off, making it a publicly traded entity from its inception on February 28, 2014. This event transferred ownership to the existing shareholders of Paladin Labs Inc. Jonathan Ross Goodman, the founder, continues to be the largest individual shareholder as of April 1, 2025, holding a substantial number of shares directly and indirectly through Long Zone Holdings Inc. This significant stake ensures his continued influence on the company's strategic vision and operations, reflecting a deep commitment to the Target Market of Knight.

Key Ownership Facts

Understanding who owns Knight Company involves recognizing its unique founding history and the substantial stake held by its founder. This structure has provided a consistent leadership and vision since the company's early days.

• Jonathan Ross Goodman is the founder and largest individual shareholder.
• Knight Therapeutics was formed through a spin-off from Paladin Labs Inc. in 2014.
• Original Paladin Labs shareholders became the initial Knight Company owners.
• Goodman's influence extends through direct holdings and control of Long Zone Holdings Inc.

Knight SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Knight Therapeutics Inc.'s journey as a publicly traded entity began on the TSX-V in March 2014, transitioning to the TSX later that year. This public listing marked the start of an evolving ownership landscape, heavily influenced by institutional investment and strategic corporate actions.

The ownership structure of Knight Therapeutics Inc. has seen notable shifts, particularly with G2S2 Capital Inc., controlled by George & Simé Armoyan, reducing its holdings to below the 10% threshold on March 21, 2025. This adjustment occurred following the disposal of 2,500,000 common shares. The company's strategic direction, including significant acquisitions like Grupo Biotoscana in 2020 and the Paladin business in June 2025, is intrinsically linked to its capital base and the composition of its shareholder group, which includes a strong presence of institutional investors.

Key Ownership Developments

Understanding who owns Knight Company involves recognizing the significant role of institutional investors. These entities play a crucial part in the company's financial stability and strategic growth initiatives.

• Knight Therapeutics Inc. commenced trading on the TSX-V on March 3, 2014.
• The company transitioned to the TSX under the symbol 'GUD' on April 29, 2014.
• Major institutional stakeholders include Industrielle Alliance, Gestion de placements inc., QV Investors Inc., and BlackRock, Inc.
• G2S2 Capital Inc. reduced its stake below 10% on March 21, 2025.
• The company's growth strategy, detailed in the Revenue Streams & Business Model of Knight, is supported by its diverse shareholder base.

Knight PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The current Board of Directors for Knight Therapeutics Inc. includes key figures like Jonathan Ross Goodman as Executive Chairman and Samira Sakhia as President, CEO, and Director. James C. Gale serves as Lead Director, supported by independent directors Robert N. Lande, Michael J. Tremblay, Nicolás Sujoy, and Janice Murray.

Jonathan Ross Goodman’s significant ownership stake as the founder positions him to influence the company's strategic direction through his board seat. The voting structure for common shares operates on a one-share-one-vote principle, as evidenced by the high 'For' vote percentages for director elections at the May 7, 2024 Annual General Meeting. This structure indicates that voting power is directly proportional to share ownership, with no immediate public information suggesting preferential voting rights for any individual or entity.

Knight Company's Boardroom Dynamics

Understanding the Knight Company owner structure involves looking at its board. The board composition reflects a blend of founder leadership, executive management, and experienced independent directors.

• Founder's influence through significant shareholding.
• Executive leadership represented by the CEO.
• Independent directors ensure governance oversight.
• Historical connections to prior entities provide industry depth.
• Voting power is tied directly to share ownership.

The Knight Company structure, particularly its board of directors, is designed to leverage the expertise of its leadership team. Jonathan Ross Goodman, as the founder and largest shareholder, plays a pivotal role in the company's governance. His substantial ownership directly translates to significant voting power, influencing key decisions. Samira Sakhia, as President and CEO, brings executive leadership and operational insight to the board. The presence of directors like James C. Gale and Robert N. Lande, with their Competitors Landscape of Knight, adds valuable historical context and industry experience. The voting results from the May 7, 2024 meeting, where directors received substantial 'For' votes, confirm the one-share-one-vote system, meaning control is distributed based on share ownership. There is no indication of dual-class shares or other mechanisms that would create disproportionate voting power for any single party, reinforcing that Knight Company ownership is primarily determined by the number of shares held.

Knight Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

In the last few years, the ownership landscape of Knight Company has seen active management through share repurchases and strategic acquisitions. These moves reflect a commitment to enhancing shareholder value and consolidating its market position.

These strategic actions underscore a dynamic approach to capital allocation and business development, aiming to strengthen the company's standing in the specialty pharmaceutical sector. The leadership transition, with Samira Sakhia becoming President and CEO on September 1, 2021, and founder Jonathan Ross Goodman moving to Executive Chairman, ensures continuity and experienced oversight.

Shareholder Value Enhancement

The company's active share repurchase programs demonstrate a commitment to returning capital to shareholders and potentially increasing earnings per share.

Strategic Market Expansion

Acquisitions and licensing agreements are key strategies for expanding market reach and product portfolios, as seen with the Paladin business and Sumitomo Pharma collaborations.

Leadership Stability

The smooth transition in leadership roles ensures that the company benefits from both new perspectives and the deep experience of its founder.

Ownership Trends Overview

Knight Company's ownership trends are shaped by proactive capital management and strategic growth initiatives, as detailed in its Brief History of Knight.

Knight Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔